Friday December 6, 2019

Passive Presence of a Romantic Partner Can Reduce Pain: Researchers

Partner empathy was positively associated with pain tolerance and inversely associated with sensory pain experience

0
//
Night-owl women not for long-term relationships: Study
In stress? Remember your romantic partner and keep BP down. pixabay

Researchers have found that the passive presence of a romantic partner can reduce pain and that partner empathy may buffer affective distress during pain exposure.

The study, published in the Scandinavian Journal of Pain, confirmed the analgesic effects of social support — even without verbal or physical contact.

The research team assessed sensitivity to pressure pain in 48 heterosexual couples with each participant tested alone and in the passive presence of their partner.

Dispositional empathy was quantified by a questionnaire.

care
Most importantly when your partner decides to confess, instead of attacking him/her, show your empathy and try to solve the issue. Pixabay

In the presence, as compared to the absence, of their partners both men and women exhibited higher pain thresholds and tolerance as well as lower sensory and affective pain ratings on constant pressure stimuli.

Partner empathy was positively associated with pain tolerance and inversely associated with sensory pain experience.

Also Read: This is How Your Brain Senses an itch

“Repeatedly, talking and touching have been shown to reduce pain, but our research shows that even the passive presence of a romantic partner can reduce it and that partner empathy may buffer affective distress during pain exposure,” said Stefan Duschek, Professor at UMIT in Austria. (IANS)

Next Story

Aspirin may Treat Acute Migraines Efficiently: Study

Aspirin can be safe option to treat migraines

0
Aspirin treats migraines
Aspirin can be considered an effective and safe option to treat acute migraines. Lifetime Stock

Aspirin can be considered an effective and safe option to other, more expensive medications to treat acute migraines as well as prevent recurrent attacks, a new study suggests.

The review, published in the American Journal of Medicine, includes evidence from 13 randomised trials of the treatment of migraine in 4,222 patients and tens of thousands of patients in prevention of recurrent attacks.

The findings suggest that high-dose aspirin, in doses from 900 to 1,300 milligrams given at the onset of symptoms, is an effective and safe treatment option for acute migraine headaches.

In addition, some but not all randomised trials suggest the possibility that daily aspirin in doses from 81 to 325 milligrams may be an effective and safe treatment option for the prevention of recurrent migraine headaches.

“Our review supports the use of high dose aspirin to treat acute migraine as well as low dose daily aspirin to prevent recurrent attacks,” said study researcher Charles H. Hennekens from Florida Atlantic University in the US.

“Moreover, the relatively favourable side effect profile of aspirin and extremely low costs compared with other prescription drug therapies may provide additional clinical options for primary health care providers treating acute as well as recurrent migraine headaches,” Hennekens added.

Aspirin
Aspirin is less expensive as compared to other medications that treat migraines. Lifetime Stock

Common symptoms of migraine include a headache that often begins as a dull pain and then grows into a throbbing pain, which can be incapacitating and often occurs with nausea and vomiting, and sensitivity to sound, light and smell.

Migraines can last anywhere from four to 72 hours and may occur as many times as several times a week to only once a year.

“Migraine headaches are among the most common and potentially debilitating disorders encountered by primary health care providers,” said study first author Bianca Biglione.

“In fact, about one in 10 primary care patients present with headache and three out of four are migraines. Aspirin is readily available without a prescription, is inexpensive, and based on our review, was shown to be effective in many migraine patients when compared with alternative more expensive therapies,” Biglion added.

Approximately 36 million Americans suffer from migraine headaches and the cause of this disabling disorder is not well understood. There is a higher prevalence in women (18 per cent) than men (nine per cent).

Also Read- Protein Deficiency Ordinary Among Indians: Experts

In women, the prevalence is highest during childbearing age.

According to the researchers, approximately 90 per cent of migraine sufferers report moderate to severe pain, with more than 50 per cent reporting severe impairment or the need for bed rest as well as reduced work or school productivity. (IANS)